Advertisement

Picture Berlin Partner Voices Robinson Data for Precision Medicine 650x100px
Financing › Details

Genoptix–Novartis: investment, 201701–201703 DIVESTMENT sale €na of Genoptix (excl biopharma business) to Ampersand + 1315 Capital + new managers

 

Period Period 2011-01-24
Organisations Money taker Genoptix Inc.
  Money source Novartis AG (NYSE: NVS)
  Group Novartis (Group)
Products Product diagnostic services
  Product 2 pharmacodiagnostic test (PDx)
Persons Person Limber, Joseph M. (Prometheus Laboratories 200711 CEO)
  Person 2 Spring, Mark (Genoptix 201703– CFO before Prometheus Laboratories)
Document Source – [GenomeWeb]. (3/7/17). "News: Novartis Completes Sale of Genoptix Lab Business". New York, NY.
     

   
Record changed: 2017-03-15

Advertisement

Picture Berlin Partner Voices Robinson Data for Precision Medicine 650x200px

More documents for Genoptix Inc.


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x300px




» top